SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459908. A total of 3 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,757 | -69.4% | 100 | -66.7% | 0.00% | – |
| Q2 2022 | $9,000 | -10.0% | 300 | 0.0% | 0.00% | – |
| Q1 2022 | $10,000 | +11.1% | 300 | 0.0% | 0.00% | – |
| Q4 2021 | $9,000 | -52.6% | 300 | -57.1% | 0.00% | – |
| Q3 2021 | $19,000 | -90.9% | 700 | -89.7% | 0.00% | – |
| Q2 2021 | $209,000 | +364.4% | 6,800 | +300.0% | 0.00% | – |
| Q1 2021 | $45,000 | -22.4% | 1,700 | -26.1% | 0.00% | – |
| Q4 2020 | $58,000 | +346.2% | 2,300 | +283.3% | 0.00% | – |
| Q3 2020 | $13,000 | -98.8% | 600 | -98.6% | 0.00% | -100.0% |
| Q2 2020 | $1,055,000 | -5.1% | 44,400 | -28.2% | 0.01% | -44.4% |
| Q1 2020 | $1,112,000 | +60.0% | 61,800 | +110.9% | 0.01% | +80.0% |
| Q4 2019 | $695,000 | -75.4% | 29,300 | -71.5% | 0.01% | -78.3% |
| Q3 2019 | $2,822,000 | +241.2% | 102,700 | +310.8% | 0.02% | +228.6% |
| Q2 2019 | $827,000 | -1.2% | 25,000 | +4.6% | 0.01% | -22.2% |
| Q1 2019 | $837,000 | +120.8% | 23,900 | +109.6% | 0.01% | +200.0% |
| Q4 2018 | $379,000 | -39.3% | 11,400 | -8.1% | 0.00% | -40.0% |
| Q3 2018 | $624,000 | -40.4% | 12,400 | -29.1% | 0.01% | -44.4% |
| Q2 2018 | $1,047,000 | +472.1% | 17,500 | +337.5% | 0.01% | +350.0% |
| Q1 2018 | $183,000 | 0.0% | 4,000 | -13.0% | 0.00% | +100.0% |
| Q4 2017 | $183,000 | -90.4% | 4,600 | -90.3% | 0.00% | -94.1% |
| Q3 2017 | $1,904,000 | -22.5% | 47,600 | -16.5% | 0.02% | -34.6% |
| Q2 2017 | $2,457,000 | +3.1% | 57,000 | -25.1% | 0.03% | -7.1% |
| Q1 2017 | $2,382,000 | +319.4% | 76,100 | +238.2% | 0.03% | +366.7% |
| Q4 2016 | $568,000 | -19.7% | 22,500 | -21.3% | 0.01% | -25.0% |
| Q3 2016 | $707,000 | -29.4% | 28,600 | -41.9% | 0.01% | -33.3% |
| Q2 2016 | $1,002,000 | +32.2% | 49,200 | -1.0% | 0.01% | +9.1% |
| Q1 2016 | $758,000 | -24.3% | 49,700 | -33.3% | 0.01% | -8.3% |
| Q4 2015 | $1,001,000 | -13.3% | 74,500 | -9.5% | 0.01% | -25.0% |
| Q3 2015 | $1,155,000 | +4.5% | 82,300 | +26.4% | 0.02% | +6.7% |
| Q2 2015 | $1,105,000 | -30.5% | 65,100 | -50.5% | 0.02% | -40.0% |
| Q1 2015 | $1,591,000 | +78.8% | 131,600 | +22.8% | 0.02% | +92.3% |
| Q4 2014 | $890,000 | -12.1% | 107,200 | -7.9% | 0.01% | -18.8% |
| Q3 2014 | $1,012,000 | -15.4% | 116,400 | +6.6% | 0.02% | -11.1% |
| Q2 2014 | $1,196,000 | +62.1% | 109,200 | +32.2% | 0.02% | +50.0% |
| Q1 2014 | $738,000 | -87.7% | 82,600 | -89.9% | 0.01% | -89.5% |
| Q3 2013 | $5,977,000 | +634.3% | 815,400 | +544.1% | 0.11% | +470.0% |
| Q2 2013 | $814,000 | – | 126,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 165 | $415,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 2,300 | $58,000 | 0.00% |